Literature DB >> 7018560

Uveitis, vitreous humour, and klebsiella. II. Cross-reactivity studies with radioimmunoassay.

J Welsh, H Avakian, A Ebringer.   

Abstract

Radioimmunoassay with calf and cow vitreous humour-I125 and rabbit antivitreous humour serum has been employed to investigate the immunological cross-reactivity of vitreous humour with bacterial and mammalian tissue antigens. Klebsiella ultrasonicate preparation at a dose fo 10 000 micrograms/ml was found to inhibit the binding of vitreous humour by 25-100% (p less than 0.001), compared with an inhibition of 5-30% by a similar quantity of E. coli ultrasonicate preparation. Equivalent amounts of Streptococcus pyogenes antigen, bovine haemoglobin, and hyaluronic acid had no inhibitory effect, while horse spleen ferritin was found to inhibit vitreous humour binding between 0 and 10%. These results indicate that klebsiella micro-organisms have antigens which partially resemble some eyeball components. It is suggested that acute anterior uveitis of ankylosing spondylitis may be produced by anti-Gram-negative bacterial antibodies binding to cross-reacting eye antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018560      PMCID: PMC1039512          DOI: 10.1136/bjo.65.5.323

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Structural studies of the capsular polysaccharide of Klebsiella type 28.

Authors:  M Curvall; B Lindberg; J Lönngren
Journal:  Carbohydr Res       Date:  1975-06       Impact factor: 2.104

2.  The relationship of specificity to affinity of anti-hapten sera.

Authors:  D Exley; H Avakian
Journal:  J Steroid Biochem       Date:  1977-11       Impact factor: 4.292

3.  Klebsiella pneumoniae and acute anterior uveitis in ankylosing spondylitis.

Authors:  R Ebringer; D Cawdell; A Ebringer
Journal:  Br Med J       Date:  1979-02-10

4.  Cross reactions between human transplantation antigens and bacterial lipopolysaccharides.

Authors:  A A Hirata; F C McIntire; P I Terasaki; K K Mittal
Journal:  Transplantation       Date:  1973-05       Impact factor: 4.939

5.  Letter: Acute anterior uveitis and HL-A 27.

Authors:  R Mapstone; J C Woodrow
Journal:  Lancet       Date:  1974-04       Impact factor: 79.321

6.  HL-A 27 and Reiter's syndrome.

Authors:  J C Woodrow
Journal:  Lancet       Date:  1973-09-22       Impact factor: 79.321

Review 7.  Natural antibodies and the immune response.

Authors:  S V Boyden
Journal:  Adv Immunol       Date:  1966       Impact factor: 3.543

Review 8.  Joseph J. Bunim Memorial Lecture. HLA-B27 and the inheritance of susceptibility to rheumatic disease.

Authors:  D A Brewerton
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

9.  Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease.

Authors:  R W Ebringer; D R Cawdell; P Cowling; A Ebringer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

10.  The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease).

Authors:  J G Schaller; G D Johnson; E J Holborow; B M Ansell; W K Smiley
Journal:  Arthritis Rheum       Date:  1974 Jul-Aug
View more
  5 in total

1.  Serum autoantibodies and uveitis.

Authors:  P Murray
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

2.  Uveitis, vitreous humor, and klebsiella. I. Binding studies with rabbit antisera.

Authors:  H Avakian; R Abuknesha; J Welsh; A Ebringer
Journal:  Br J Ophthalmol       Date:  1981-05       Impact factor: 4.638

3.  Acute anterior uveitis and hepatitis B virus infection.

Authors:  P I Murray; J Waite; A H Rahi; R S Tedder
Journal:  Br J Ophthalmol       Date:  1984-08       Impact factor: 4.638

4.  Chlamydial immunofluorescence serology in anterior uveitis.

Authors:  L Mattila; L Salminen; P Terho
Journal:  Br J Ophthalmol       Date:  1982-10       Impact factor: 4.638

5.  Klebsiella and acute anterior uveitis.

Authors:  A B Beckingsale; D Williams; J M Gibson; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1984-12       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.